Target intelligence / Profile preview

MTUS2 antisense RNA 2 (MTUS2-AS2)

Target
MTUS2-AS2
Molecular classification
Antisense RNA, Long non-coding RNA, lncRNA
01

Overview

MTUS2 antisense RNA 2 (MTUS2-AS2) is a long non-coding antisense RNA gene located antisense to the coding gene MTUS2 on chromosome 13[1][4]. It does not encode any protein and belongs to the molecular class of lncRNAs, specifically antisense RNAs, as defined by the HGNC[1][6]. By virtue of its antisense orientation, MTUS2-AS2 may be involved in the regulation of MTUS2 gene expression, possibly affecting transcription, mRNA stability, or translation through various mechanisms such as RNA-RNA interactions, chromatin modification, or influencing three-dimensional chromatin organization[5][8]. There is no current evidence that MTUS2-AS2 is itself a direct target for therapeutic drugs, nor is it established as a disease biomarker. The biological roles of MTUS2-AS2 remain incompletely elucidated, typical of many antisense lncRNAs, but it may participate in gene regulatory networks and epigenetic modulation[1][5][6]. No documented disease associations, drug interactions, or safety concerns are associated with MTUS2-AS2 at this time[1][4][7].

Other names
MTUS2 antisense RNA 2 (non-protein coding)MTUS2-AS2
02

Biological functions

Regulation of gene expression (by overlapping the MTUS2 locus, MTUS2-AS2 may influence its transcription and function, as antisense lncRNAs often do)Potential involvement in epigenetic regulation (common for antisense RNAs)
03

Disease associations

Other (No direct association with specific diseases such as cancer, inflammation, neurodegeneration, or cardiovascular disease has been documented for MTUS2-AS2 itself. Its sense counterpart, MTUS2, is implicated in neurologic neoplasms, but not the antisense RNA.)

Beyond the preview

Go deeper on MTUS2 antisense RNA 2 (MTUS2-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MTUS2 antisense RNA 2 (MTUS2-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call